Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |